Skip to content

Brief Cognitive Behavior Therapy (B-CBT) for Depressive Symptoms, Death Anxiety, Quality of Life and Adherence to Treatment among Patients with Breast Cancer Stage-II (BC-S-II). A Randomized Control Trial

Brief Cognitive Behavior Therapy (B-CBT) for Depressive Symptoms, Death Anxiety, Quality of Life and Adherence to Treatment among Patients with Breast Cancer Stage-II (BC-S-II). A Randomized Control Trial

Status
Unknown
Phases
Early Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20240817003
Enrollment
165
Registered
2024-08-17
Start date
2024-08-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brest cancer patients Brest Cancer patients

Interventions

Brief CBT would be given to breast cancer patient&#039
s,no intervention would be given to participants
Experimental Behavioral,No Intervention No treatment

Sponsors

None listed

Eligibility

Sex/Gender
Female
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: The patients diagnosed with breast cancer patients with stage II. female aged 20-50 years would participate in our study. The participants from different hospitals or clinic of Islamabad would be included in our study.

Exclusion criteria

Exclusion criteria: The patient with other stages of cancer and type of cancer such as skin cancer, lungs cancer etc would be excluded from our study. The patient with other serious co-morbid medical illness such as diabetes, heart problems, and stroke will be excluded from our study. The patient with physical disability would be excluded from our study.

Design outcomes

Primary

MeasureTime frame
Health Anxiety Scale 6 months Pre and post assessment through scale ,Patient Heath Quetionnaire 6 Monthd Pre and post assessment through scale ,Death Anxiety Scale 6 months Pre and post assessment through scale ,Quality of life Scale 6 months Pre and post assessment through scale ,Treatment adherence scale 6 months Pre and post assessment through scale

Secondary

MeasureTime frame
severity level and impact of medication 6 month demographics pre and post assesmet

Countries

Pakistan

Contacts

Public ContactWizra Saeed

Bahria University Islamabad Campus

wizrasaeed@gmail.com03367718195

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026